Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BASF prepares dolastatin derivatives

Feb. 14, 1997

Retinoid series for cancer

Feb. 14, 1997

Idec acquires rights to anticancer agent

Feb. 13, 1997

Basal lamina-based drugs offer promise for tumor metastasis

Feb. 13, 1997

Supplemental NDA filed for Photofrin

Feb. 13, 1997

Orphan Medical expands clinical trials of Busulfanex

Feb. 13, 1997

Sugen reports modulators of tyrosine signal transduction

Feb. 13, 1997

Anticancer agents from Takeda

Feb. 13, 1997

Antineoplastic retinoid compounds disclosed

Feb. 12, 1997

U.K. launch for SKB anticancer treatment

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...